Long-Term Outcomes of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) Technique in Patients With Aorto-Iliac Occlusive Disease

Abstract

Background:

The Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) reconstruction is an endovascular technique, developed to reconstruct the aortic bifurcation in the most optimal anatomical and physiological manner. Short-term data were promising, but long-term data are still lacking. The objective was to report the long-term outcomes of CERAB for extensive aorto-iliac occlusive disease and to identify predictors for loss of primary patency.

Methods:

Consecutive electively treated patients with CERAB for aorto-iliac occlusive disease in a single hospital were identified and analyzed. Baseline and procedural data and follow-up were collected at 6-weeks, 6 months, 12 months, and annually thereafter. Technical success, procedural, and 30-day complications were evaluated, as well as overall survival. Patency and freedom from target lesion revascularization rates were analyzed using Kaplan Meier curves. Uni- and multivariate analysis were performed to identify possible predictors of failure.

Results:

One hundred and sixty patients were included (79 male). Indication for treatment was intermittent claudication for 121 patients (75.6%) and 133 patients (83.1%) had a TASC-II D lesion. Technical success was obtained in 95.6% of patients and the 30-day mortality rate was 1.3%. The 5-year primary, primary-assisted, and secondary patency rates were 77.5%, 88.1%, and 95.0%, respectively, with a freedom-from clinically driven target lesion revascularization (CD-TLR) rate of 84.4%. The strongest predictor of loss of primary patency of CERAB was a previous aorto-iliac intervention (odds ratio [OR]=5.36 (95% confidence interval [CI]: 1.30; 22.07), p=0.020). In patients not previously treated in the aorto-iliac tract, 5-year primary, primary assisted, and secondary patency rates were 85.1%, 94.4%, and 96.9%, respectively. At 5-year follow-up, an improved Rutherford was found in 97.9% of patients and the freedom from major amputation rate was 100%.

Conclusion:

The CERAB technique is related to good long-term outcomes, particularly in primary cases. In patients that had prior treatment for aorto-iliac occlusive disease, there were more reinterventions and therefore surveillance should likely be more intense.

Clinical Impact

The Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) reconstruction was designed to improve outcomes of endovascular treatment of extensive aorto-iliac occlusive disease. At 5-year follow-up clinical improvement was found in 97.9% of patients without major amputations. The 5-year overall primary, primary-assisted, and secondary patency rates were 77.5%, 88.1%, and 95.0%, respectively, with a freedom-from clinically driven target lesion revascularization rate of 84.4%. Significantly better patency rates were observed for patients that were never treated before in the target area. The data implicate that CERAB are a valid treatment option for patients with extensive aorto-iliac occlusive disease. For patients previously treated in the target area, other treatment options might be considered, or more intensive follow-up surveillance is warranted.

Keywords

aorto-iliac atherosclerosis AIOD peripheral arterial disease CERAB balloon-expandable covered stent endovascular

Get full access to this article

View all access options for this article.

References

Aboyans

Ricco

J-B

Bartelink

M-LEL

, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2017;39(9):763–816.

Borghese

Ferrer

Coscarella

, et al. Two-year single centre results with covered endovascular reconstruction of aortic bifurcation (CERAB) in the treatment of extensive aorto-iliac occlusive disease. Vascular. 2022;30(3):500–508.

García

Gómez-Rodríguez

Cabrera-Vargas

, et al. Midterm outcomes of the covered endovascular reconstruction of the aortic bifurcation for aortoiliac occlusive disease in a latinoamerican population. Int J Surg Case Rep. 2021;88:106572.

de Cort

Salemans

Fritschy

, et al. Long-term outcome for covered endovascular reconstruction of aortic bifurcation for aortoiliac disease: a single-center experience. J Endovasc Ther. 2021;28(6):906–913.

Saratzis

Salem

Sabbagh

, et al. Treatment of aortoiliac occlusive disease with the covered endovascular reconstruction of the aortic bifurcation (CERAB) technique: results of a UK multicenter study. J Endovasc Ther. 2021;28(5):737–745.

Fujihara

Takahara

Yamaoka

, et al. Clinical outcomes of endovascular procedure using VIABAHN® VBX covered stent in complex aortoiliac artery disease: result from AVOCADO study. Catheter Cardiovasc Interv. 2021;98(5):928–937.

Taeymans

Groot Jebbink

Holewijn

, et al. Three-year outcome of the covered endovascular reconstruction of the aortic bifurcation technique for aortoiliac occlusive disease. J Vasc Surg. 2018;67(5):1438–1447.

Dijkstra

Goverde

Holden

, et al. Initial experience with covered endovascular reconstruction of the aortic bifurcation in conjunction with chimney grafts. J Endovasc Ther. 2017;24(1):19–24.

Grimme

Goverde

Verbruggen

, et al. Editor’s choice—first results of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) technique for aortoiliac occlusive disease. Eur J Vasc Endovasc Surg. 2015;50(5):638–647.

10.

Rutherford

Baker

Ernst

, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26(3):517–538.

11.

Jaff

White

Hiatt

, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Vasc Med. 2015;20(5):465–478.

12.

Norgren

Hiatt

Dormandy

, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5–S67.

13.

Davis

Marin

Hurwitz

, et al. Application of a novel CT-based iliac artery calcification scoring system for predicting renal transplant outcomes. AJR Am J Roentgenol. 2016;206(2):436–441.

14.

Reijnen

MM.

Update on covered endovascular reconstruction of the aortic bifurcation. Vascular. 2020;28(3):225–232.

15.

Goverde

Grimme

Verbruggen

, et al. Covered endovascular reconstruction of aortic bifurcation (CERAB) technique: a new approach in treating extensive aortoiliac occlusive disease. J Cardiovasc Surg. 2013;54(3):383–387.

16.

Stoner

Calligaro

Chaer

, et al. Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease: executive summary. J Vasc Surg. 2016;64(1):227–228.

17.

Filippiadis

Binkert

Pellerin

, et al. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40(8):1141–1146.

18.

Salem

Hosny

Francia

, et al. Management of extensive aorto-iliac disease: a systematic review and meta-analysis of 9319 patients. Cardiovasc Intervent Radiol. 2021;44(10):1518–1535.

19.

Groot Jebbink

Holewijn

Versluis

, et al. Meta-analysis of individual patient data after kissing stent treatment for aortoiliac occlusive disease. J Endovasc Ther. 2019;26(1):31–40.

20.

Groot Jebbink

Engelhard

Lajoinie

, et al. Influence of iliac stenotic lesions on blood flow patterns near a covered endovascular reconstruction of the aortic bifurcation (CERAB) stent configuration. J Endovasc Ther. 2017;24(6):800–808.